ORAL ANTI-TUMOR DRUGS
Clinical trials for ORAL ANTI-TUMOR DRUGS explained in plain language.
Never miss a new study
Get alerted when new ORAL ANTI-TUMOR DRUGS trials appear
Sign up with your email to follow new studies for ORAL ANTI-TUMOR DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pharmacists get training to better support cancer patients on oral medications
Knowledge-focused Not yet recruitingThis pilot study tests whether an educational program can help community pharmacists better support patients taking oral anticancer drugs. Thirty registered pharmacists in Malaysia will be randomly assigned to either attend the program or a control group. Researchers will measure…
Matched conditions: ORAL ANTI-TUMOR DRUGS
Phase: NA • Sponsor: Monash University Malaysia • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Study to test if patient education improves side effect management for neuroendocrine tumor patients on oral therapy
Knowledge-focused Not yet recruitingThis study will enroll 100 adults with neuroendocrine tumors who are starting oral anti-cancer drugs like everolimus or sunitinib. Researchers want to see if a therapeutic education program—including questionnaires and nurse consultations—helps patients handle side effects and ma…
Matched conditions: ORAL ANTI-TUMOR DRUGS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC